ClinTrials revenues from Sandoz totaled $14.5 mil. in 1995, CRO's 2.6 mil.-share offering discloses.
CLINTRIALS REVENUES FROM SANDOZ TOTALED $14.5 MIL. IN 1995, the clinical research organization reports in a June 27 public offering prospectus. Sandoz, one of three clients with whom ClinTrials has entered into strategic alliances, accounted for approximately 25% of ClinTrials' net service revenues of $57.9 mil., the prospectus states. SmithKline Beecham, another ClinTrials partner, accounted for 18% of net service revenues, or $10.4 mil. Baxter is ClinTrials' third strategic partner.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth